The Arterial Blood Collection Devices Market in North America is witnessing steady growth as healthcare providers increasingly use specialized collection systems to obtain arterial blood samples for blood gas analysis and critical diagnostic evaluation.
Market Overview
The arterial blood collection devices market was valued at US$ 1.24 Billion in 2025 and is projected to reach US$ 1.93 Billion by 2034, expanding at a CAGR of 5.07% during 2026–2034. The market encompasses specialized collection technologies supporting arterial blood gas sampling, intraoperative blood salvage, critical care monitoring, and related diagnostic workflows. Demand is shaped by acute-care utilization, specimen-quality requirements, healthcare-worker safety, and increasing preference for standardized, pre-heparinized collection systems.
What is Driving the Arterial Blood Collection Devices Market?
The increasing burden of respiratory diseases, cardiovascular conditions, metabolic disorders, and critical illnesses is driving demand for arterial blood gas testing and related collection devices. Hospitals and emergency departments require reliable sampling solutions to obtain blood specimens quickly while minimizing patient discomfort and the risk of sample contamination. Growing critical care capacity, increasing use of point-of-care blood gas analyzers, and greater emphasis on rapid clinical decision-making are also supporting demand. In addition, manufacturers are developing safer needles, syringes, and collection systems with improved handling and specimen stability.
Which Region Leads the Arterial Blood Collection Devices Market?
North America is expected to hold a prominent position in the Arterial Blood Collection Devices Market, supported by advanced healthcare infrastructure, high adoption of diagnostic technologies, and the strong presence of hospitals and critical care facilities. The US contributes significantly to regional demand due to the widespread use of arterial blood gas testing in intensive care, emergency medicine, respiratory care, and surgical settings. Europe also represents an important region, supported by established healthcare systems and increasing demand for efficient diagnostic procedures. Meanwhile, Asia Pacific is expected to present growth opportunities as healthcare infrastructure expands and access to critical care and diagnostic services improves.
Which Segment Leads the Arterial Blood Collection Devices Market?
The arterial blood gas syringe segment represents a key product category due to its widespread use for collecting and transporting arterial blood specimens for blood gas analysis. Pre-heparinized syringes are particularly important because they help reduce preparation time and support sample integrity during testing. Hospitals and diagnostic laboratories are major end users, while intensive care units, emergency departments, operating rooms, and respiratory care units account for significant utilization. Increasing adoption of point-of-care testing is further supporting demand for convenient and reliable arterial blood collection products.
Which Companies are Prominent in the Arterial Blood Collection Devices Market?
Prominent companies associated with the Arterial Blood Collection Devices Market include:Bio-Rad Laboratories, Inc.; NIPRO CORPORATION; QIAGEN N.V.; F. Hoffmann-La Roche Ltd; Terumo Corporation; Thermo Fisher Scientific Inc.; Becton, Dickinson and Company; Medtronic plc.; Greiner Bio-One International GmbH; Narang Medical Limited.
These companies are focusing on product innovation, safety improvements, manufacturing capabilities, and distribution expansion to address growing demand for efficient blood collection solutions.
Get Full Report: https://www.theinsightpartners.com/buy/TIPRE00018021
What is Changing in the Arterial Blood Collection Devices Market in 2026?
In 2026, the market is being influenced by the increasing integration of arterial blood collection with rapid and point-of-care diagnostic workflows. Healthcare providers are seeking collection devices that improve sample quality, simplify handling, reduce preanalytical errors, and support faster clinical decision-making. Manufacturers are also emphasizing ergonomic designs, pre-filled anticoagulant systems, safety mechanisms, and products that help reduce exposure risks for healthcare professionals. The growing adoption of decentralized diagnostic testing and improvements in blood gas analysis technologies are expected to further influence product development.
What are the Major Investment Opportunities?
Investment opportunities are emerging in advanced arterial blood collection systems, safety-engineered devices, pre-heparinized syringes, and products designed for point-of-care testing environments. Manufacturers can benefit from increasing healthcare expenditure, expanding intensive care capacity, and growing demand for rapid diagnostic testing in emerging economies. Research and development focused on improving specimen stability, reducing sample volume requirements, enhancing user safety, and simplifying blood collection procedures can also create opportunities for product differentiation and market expansion.
Related Reports
Dental Market Growth, Trends, and Analysis by 2028
Dental Silicone Materials Market Size, Demand & Growth by 2034
About US
The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.
Contact Us
Contact Person: Ankit Mathur
E-mail:ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876
Also Available in : Korean German Japanese French Chinese Italian Spanish
